Geode Capital Management, LLC Bio Affinity Technologies, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 125,459 shares of BIAF stock, worth $35,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,459
Previous 118,689
5.7%
Holding current value
$35,128
Previous $30,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BIAF
# of Institutions
20Shares Held
416KCall Options Held
0Put Options Held
0-
Sheaff Brock Investment Advisors, LLC53.7KShares$15,0450.0% of portfolio
-
Allworth Financial LP53.7KShares$15,0450.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.6KShares$11,3790.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$7,8070.0% of portfolio
-
Ifp Advisors, Inc25KShares$7,0000.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $764K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...